I. Barone, L. Brusco, and S. Fuqua, Estrogen Receptor Mutations and Changes in Downstream Gene Expression and Signaling, Clinical Cancer Research, vol.16, issue.10, pp.2702-2708, 2010.
DOI : 10.1158/1078-0432.CCR-09-1753

H. Rochefort, N. Platet, Y. Hayashido, D. Derocq, A. Lucas et al., Estrogen receptor mediated inhibition of cancer cell invasion and motility: An overview, The Journal of Steroid Biochemistry and Molecular Biology, vol.65, issue.1-6, pp.163-168, 1998.
DOI : 10.1016/S0960-0760(98)00010-7

N. Platet, S. Cunat, D. Chalbos, H. Rochefort, and M. Garcia, Unliganded and Liganded Estrogen Receptors Protect against Cancer Invasion via Different Mechanisms, Molecular Endocrinology, vol.14, issue.7, pp.999-1009, 2000.
DOI : 10.1210/mend.14.7.0492

G. Kerdivel, G. Flouriot, and F. Pakdel, Modulation of Estrogen Receptor Alpha Activity and Expression During Breast Cancer Progression, Vitam Horm, vol.93, pp.135-160, 2013.
DOI : 10.1016/B978-0-12-416673-8.00004-6
URL : https://hal.archives-ouvertes.fr/hal-00874313

N. Platet, A. Cathiard, M. Gleizes, and M. Garcia, Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion, Critical Reviews in Oncology/Hematology, vol.51, issue.1, pp.55-67, 2004.
DOI : 10.1016/j.critrevonc.2004.02.001
URL : https://hal.archives-ouvertes.fr/inserm-00144757

J. Kim, T. Kurita, and S. Bulun, Progesterone Action in Endometrial Cancer, Endometriosis, Uterine Fibroids, and Breast Cancer, Endocrine Reviews, vol.34, issue.1, pp.130-162, 2013.
DOI : 10.1210/er.2012-1043

M. Pegram, G. Konecny, and D. Slamon, The Molecular and Cellular Biology of HER2/neu Gene Amplification/Overexpression and the Clinical Development of Herceptin (Trastuzumab) Therapy for Breast Cancer, Cancer Treat Res, vol.103, pp.57-75, 2000.
DOI : 10.1007/978-1-4757-3147-7_4

R. Métivier, F. Gay, M. H\übner, G. Flouriot, G. Salbert et al., Formation of an hERalpha-COUP-TFI complex enhances hERalpha AF-1 through Ser118 phosphorylation by MAPK, The EMBO Journal, vol.21, issue.13, pp.3443-3453, 2002.
DOI : 10.1093/emboj/cdf344

L. Dily, F. Métivier, R. Guéguen, M. , L. Péron et al., COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells, Breast Cancer Research and Treatment, vol.24, issue.2, pp.69-83, 2007.
DOI : 10.1007/s10549-007-9693-6
URL : https://hal.archives-ouvertes.fr/hal-00285849

J. Park, S. Tsai, and M. Tsai, Molecular mechanism of chicken ovalbumin upstream promoter-transcription factor (COUP-TF) actions, The Keio Journal of Medicine, vol.52, issue.3, pp.174-181, 2003.
DOI : 10.2302/kjm.52.174

A. Boudot, L. Dily, F. Pakdel, and F. , Involvement of COUP-TFs in Cancer Progression, Cancers, vol.3, issue.4, pp.700-715, 2011.
DOI : 10.3390/cancers3010700
URL : https://hal.archives-ouvertes.fr/hal-00750351

S. Nagasaki, T. Suzuki, Y. Miki, J. Akahira, H. Shibata et al., Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: Possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expression, Cancer Science, vol.270, issue.4, pp.639-645, 2009.
DOI : 10.1111/j.1349-7006.2008.01078.x

J. Qin, S. Wu, C. Creighton, F. Dai, X. Xie et al., COUP-TFII inhibits TGF-??-induced growth barrier to promote prostate tumorigenesis, Nature, vol.18, issue.7431, pp.236-240, 2013.
DOI : 10.1038/nature11674

S. Hawkins, H. Loomans, Y. Wan, T. Ghosh-choudhury, D. Coffey et al., Expression and Functional Pathway Analysis of Nuclear Receptor NR2F2 in Ovarian Cancer, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.7, pp.1152-1162, 2013.
DOI : 10.1210/jc.2013-1081

X. Sun, G. Cheng, M. Hao, J. Zheng, X. Zhou et al., CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression, Cancer and Metastasis Reviews, vol.89, issue.1, pp.709-722, 2010.
DOI : 10.1007/s10555-010-9256-x
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175097

K. Luker and G. Luker, Functions of CXCL12 and CXCR4 in breast cancer, Cancer Letters, vol.238, issue.1, pp.30-41, 2006.
DOI : 10.1016/j.canlet.2005.06.021

A. M\üller, B. Homey, H. Soto, N. Ge, D. Catron et al., Involvement of chemokine receptors in breast cancer metastasis, Nature, vol.410, issue.6824, pp.50-56, 2001.
DOI : 10.1038/35065016

H. Kang, G. Watkins, C. Parr, D. , A. Mansel et al., Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer, Breast Cancer Research, vol.5, issue.4, pp.402-410, 2005.
DOI : 10.1186/bcr627

J. Burger and T. Kipps, CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment, Blood, vol.107, issue.5, pp.1761-1767, 2006.
DOI : 10.1182/blood-2005-08-3182

M. Wendt, A. Cooper, and M. Dwinell, Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells, Oncogene, vol.63, issue.10, pp.1461-1471, 2008.
DOI : 10.1038/31269

W. Zhou, Z. Jiang, N. Liu, F. Xu, P. Wen et al., Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas, Journal of Cancer Research and Clinical Oncology, vol.119, issue.1, pp.91-102, 2009.
DOI : 10.1007/s00432-008-0435-x

M. Wendt, P. Johanesen, N. Kang-decker, D. Binion, V. Shah et al., Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis, Oncogene, vol.393, issue.36, pp.4986-4997, 2006.
DOI : 10.1038/sj.onc.1209505

A. Boudot, G. Kerdivel, D. Habauzit, J. Eeckhoute, L. Dily et al., Differential Estrogen-Regulation of CXCL12 Chemokine Receptors, CXCR4 and CXCR7, Contributes to the Growth Effect of Estrogens in Breast Cancer Cells, PLoS ONE, vol.132, issue.6, p.20898, 2011.
DOI : 10.1371/journal.pone.0020898.s002
URL : https://hal.archives-ouvertes.fr/hal-00605459

J. Vandesompele, D. Preter, K. Pattyn, F. Poppe, B. Van-roy et al., Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol, vol.3, p.34, 2002.

J. Eeckhoute, M. Lupien, C. Meyer, M. Verzi, R. Shivdasani et al., Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers, Genome Research, vol.19, issue.3, pp.372-380, 2008.
DOI : 10.1101/gr.084582.108
URL : https://hal.archives-ouvertes.fr/hal-00369667

H. Kishimoto, Z. Wang, P. Bhat-nakshatri, D. Chang, R. Clarke et al., The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1??/CXCL12, Carcinogenesis, vol.26, issue.10, p.1706, 2005.
DOI : 10.1093/carcin/bgi137

E. Moré, T. Fellner, H. Doppelmayr, C. Hauser-kronberger, N. Dandachi et al., Activation of the MAP kinase pathway induces chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) expression in human breast cancer cell lines, Journal of Endocrinology, vol.176, issue.1, pp.83-94, 2003.
DOI : 10.1677/joe.0.1760083

P. Nagy, M. Cleary, P. Brown, and J. Lieb, Genomewide demarcation of RNA polymerase II transcription units revealed by physical fractionation of chromatin, Proceedings of the National Academy of Sciences, vol.100, issue.11, pp.6364-6369, 2003.
DOI : 10.1073/pnas.1131966100

F. Petit, R. Métivier, Y. Valotaire, and F. Pakdel, Synergism between a half-site and an imperfect estrogen-responsive element, and cooperation with COUP-TFI are required for estrogen receptor (ER) to achieve a maximal estrogen-stimulation of rainbow trout ER gene, European Journal of Biochemistry, vol.10, issue.1-2, pp.385-395, 1999.
DOI : 10.1046/j.1432-1327.1999.00072.x

M. Rahimi, J. George, and C. Tang, EGFR variant-mediated invasion by enhanced CXCR4 expression through transcriptional and post-translational mechanisms, International Journal of Cancer, vol.5, pp.1850-1860, 2010.
DOI : 10.1002/ijc.24964

J. Burbach, S. Lopes-da-silva, J. Cox, R. Adan, A. Cooney et al., Repression of estrogen-dependent stimulation of the oxytocin gene by chicken ovalbumin upstream promoter transcription factor I, J Biol Chem, vol.269, pp.15046-15053, 1994.

Y. Liu, N. Yang, and C. Teng, COUP-TF acts as a competitive repressor for estrogen receptor-mediated activation of the mouse lactoferrin gene., Molecular and Cellular Biology, vol.13, issue.3, pp.1836-1846, 1993.
DOI : 10.1128/MCB.13.3.1836

X. Lu and Y. Kang, Epidermal growth factor signalling and bone metastasis, British Journal of Cancer, vol.63, issue.3, pp.457-461, 2010.
DOI : 10.1074/jbc.M705064200

J. Foley, N. Nickerson, S. Nam, K. Allen, J. Gilmore et al., EGFR signaling in breast cancer: Bad to the bone, Seminars in Cell & Developmental Biology, vol.21, issue.9, pp.951-960, 2010.
DOI : 10.1016/j.semcdb.2010.08.009

T. Nakayama, N. Mutsuga, and G. Tosato, FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc, Blood, vol.109, issue.4, pp.1363-1372, 2007.
DOI : 10.1182/blood-2006-06-028217

T. Nakayama, N. Mutsuga, and G. Tosato, Effect of Fibroblast Growth Factor 2 on Stromal Cell-Derived Factor 1 Production by Bone Marrow Stromal Cells and Hematopoiesis, JNCI Journal of the National Cancer Institute, vol.99, issue.3, pp.223-235, 2007.
DOI : 10.1093/jnci/djk031

N. Wright, T. De-lera, C. García-moruja, R. Lillo, F. García-sánchez et al., Transforming growth factor-??1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion, Blood, vol.102, issue.6, pp.1978-1984, 2003.
DOI : 10.1182/blood-2002-10-3190

J. Grandis and J. Sok, Signaling through the epidermal growth factor receptor during the development of malignancy, Pharmacology & Therapeutics, vol.102, issue.1, pp.37-46, 2004.
DOI : 10.1016/j.pharmthera.2004.01.002

D. Uchida, T. Onoue, N. Kuribayashi, Y. Tomizuka, T. Tamatani et al., Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases, European Journal of Cancer, vol.47, issue.3, pp.452-459, 1990.
DOI : 10.1016/j.ejca.2010.09.028

G. Chen, Z. Wang, X. Liu, and F. Liu, High-Level CXCR4 Expression Correlates with Brain-Specific Metastasis of Non-Small Cell Lung Cancer, World Journal of Surgery, vol.2, issue.1, pp.56-61, 2011.
DOI : 10.1007/s00268-010-0784-x

B. Furusato, A. Mohamed, M. Uhlén, and J. Rhim, CXCR4 and cancer, CXCR4 and cancer, pp.497-505, 2010.
DOI : 10.1111/j.1440-1827.2010.02548.x

B. Zabel, Y. Wang, S. Lewén, R. Berahovich, M. Penfold et al., Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands, The Journal of Immunology, vol.183, issue.5, pp.3204-3211, 1950.
DOI : 10.4049/jimmunol.0900269

M. Christopher, F. Liu, M. Hilton, F. Long, and D. Link, Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization, Blood, vol.114, issue.7, pp.1331-1339, 2009.
DOI : 10.1182/blood-2008-10-184754

M. Calonge, J. Seoane, and J. Massagué, Opposite Smad and Chicken Ovalbumin Upstream Promoter Transcription Factor Inputs in the Regulation of the Collagen VII Gene Promoter by Transforming Growth Factor-??, Journal of Biological Chemistry, vol.279, issue.22, pp.23759-23765, 2004.
DOI : 10.1074/jbc.M402178200

H. Connor, H. Nornes, and T. Neuman, Expression Screening Reveals an Orphan Receptor Chick Ovalbumin Upstream Promoter Transcription Factor I as a Regulator of Neurite/Substrate-Cell Contacts and Cell Aggregation, Journal of Biological Chemistry, vol.270, issue.25, pp.15066-15070, 1995.
DOI : 10.1074/jbc.270.25.15066

B. Pradet-balade, F. Boulmé, H. Beug, E. Müllner, and J. Garcia-sanz, Translation control: bridging the gap between genomics and proteomics?, Trends in Biochemical Sciences, vol.26, issue.4, pp.225-229, 2001.
DOI : 10.1016/S0968-0004(00)01776-X